Literature DB >> 29164380

Correlation between the availability of dopamine transporter and olfactory function in healthy subjects.

Kyoungjune Pak1, Keunyoung Kim1, Myung Jun Lee2, Jae Meen Lee3, Bum Soo Kim4, Seong-Jang Kim5, In Joo Kim1.   

Abstract

OBJECTIVES: Olfactory dysfunction in Parkinson's disease is usually prodromal to other symptoms. In this study, we aimed to explore the association of olfactory function with the availabilities of striatal dopamine transporter (DAT) in healthy subjects.
METHODS: Data used in the preparation of this article were obtained from Parkinson's Progression Markers Initiative database ( www.ppmi-info.org/data ). The study population consisted of healthy controls with screening 123I-FP-CIT single photon emission tomography (SPECT). University of Pennsylvania Smell Identification Test (UPSIT) was assessed to evaluate the olfactory function.
RESULTS: Totally, 181 healthy subjects (117 male, 64 female) with 123I-FP-CIT SPECT data were included in this study. Specific binding ratios (SBRs) of the caudate nucleus (rho = -0.4217, p < 0.0001), putamen (rho = -0.2292, p = 0.0019), and striatum (rho=-0.3425, p < 0.0001) showed a reduction with ageing. SBRs of the caudate nucleus, putamen, and striatum were positively correlated with UPSIT (rho = 0.3716, p < 0.0001; rho = 0.3655, p < 0.0001; rho = 0.3880, p < 0.0001). After controlling for age by partial correlation, SBRs of the caudate nucleus, putamen, and striatum showed an influence on UPSIT (rho = 0.3288, p < 0.0001; rho = 0.3374, p < 0.0001; rho = 0.3511, p < 0.0001).
CONCLUSION: Olfactory function is associated with the availability of striatal DAT independent of age in healthy subjects. KEY POINTS: • Olfactory dysfunction in Parkinson's disease is prodromal to other symptoms. • The availability of dopamine transporter showed a reduction with ageing. • Olfactory function is associated with the availability of dopamine transporter.

Entities:  

Keywords:  Brain; Dopamine plasma membrane transport proteins; Nuclear medicine; Smell; Tomography, emission computed, single photon

Mesh:

Substances:

Year:  2017        PMID: 29164380     DOI: 10.1007/s00330-017-5147-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

Review 1.  60 Years of Achievements by KSNM in Neuroimaging Research.

Authors:  Jae Seung Kim; Hye Joo Son; Minyoung Oh; Dong Yun Lee; Hae Won Kim; Jungsu Oh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-15

2.  Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT.

Authors:  Helen Schmitz-Steinkrüger; Catharina Lange; Ivayla Apostolova; Franziska L Mathies; Lars Frings; Susanne Klutmann; Sabine Hellwig; Philipp T Meyer; Ralph Buchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-31       Impact factor: 9.236

3.  Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.

Authors:  Thomas G Beach; Charles H Adler; Nan Zhang; Geidy E Serrano; Lucia I Sue; Erika Driver-Dunckley; Shayamal H Mehta; Edouard E Zamrini; Marwan N Sabbagh; Holly A Shill; Christine M Belden; David R Shprecher; Richard J Caselli; Eric M Reiman; Kathryn J Davis; Kathy E Long; Lisa R Nicholson; Anthony J Intorcia; Michael J Glass; Jessica E Walker; Michael M Callan; Javon C Oliver; Richard Arce; Richard C Gerkin
Journal:  PLoS One       Date:  2020-04-22       Impact factor: 3.240

4.  Event-Related Potentials Elicited by Face and Face Pareidolia in Parkinson's Disease.

Authors:  Gulsum Akdeniz; Gonul Vural; Sadiye Gumusyayla; Hesna Bektas; Orhan Deniz
Journal:  Parkinsons Dis       Date:  2020-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.